Puma Biotechnology (PBYI) Inventory Average (2017 - 2026)

Puma Biotechnology has reported Inventory Average for 10 years, with the latest figure at $7.1 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 18.7% year-over-year to $7.1 million; the trailing twelve-month figure through Mar 2026 stood at $7.1 million (down 18.7% YoY), and the FY2025 full-year result was $7.1 million, down 9.9% from the prior year.
• Inventory Average for Q1 2026 stood at $7.1 million, down from $7.5 million in the prior quarter.
• The five-year high for Inventory Average was $9.0 million in Q3 2025, with the low at $4.2 million in Q1 2023.
• Historically, Inventory Average has averaged $6.8 million across 5 years, with a median of $7.0 million in 2022.
• Annual changes were most pronounced in 2023 — Inventory Average plunged 41.49% — and 2024, when it jumped 68.47%.
• Puma Biotechnology's Inventory Average stood at $5.0 million in 2022, then gained by 27.87% to $6.4 million in 2023, then fell by 10.67% to $5.7 million in 2024, then soared by 31.53% to $7.5 million in 2025, then decreased by 5.22% to $7.1 million in 2026.
• The last three Inventory Average figures came in at $7.1 million (Q1 2026), $7.5 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.